Tumor Uptake of ⁶⁴ Cu-DOTA-Trastuzumab in Patients with Metastatic Breast Cancer.

Autor: Mortimer JE; Department of Medical Oncology and Experimental Therapeutics, City of Hope, Duarte, California jmortimer@coh.org., Bading JR; Department of Medical Oncology and Experimental Therapeutics, City of Hope, Duarte, California., Park JM; Department of Radiology, City of Hope, Duarte, California., Frankel PH; Department of Information Sciences, City of Hope, Duarte, California., Carroll MI; Department of Medical Oncology and Experimental Therapeutics, City of Hope, Duarte, California., Tran TT; Department of Radiology, City of Hope, Duarte, California., Poku EK; Department of Cancer Immunotherapy and Tumor Immunology, Beckman Research Institute of the City of Hope, Duarte, California; and., Rockne RC; Department of Information Sciences, City of Hope, Duarte, California., Raubitschek AA; Department of Cancer Immunotherapy and Tumor Immunology, Beckman Research Institute of the City of Hope, Duarte, California; and., Shively JE; Department of Immunology, Beckman Research Institute of the City of Hope, Duarte, California., Colcher DM; Department of Cancer Immunotherapy and Tumor Immunology, Beckman Research Institute of the City of Hope, Duarte, California; and.

Publikováno v: Journal of nuclear medicine : official publication, Society of Nuclear Medicine [J Nucl Med] 2018 Jan; Vol. 59 (1), pp. 38-43. Date of Electronic Publication: 2017 Jun 21.

Functional imaging of human epidermal growth factor receptor 2-positive metastatic breast cancer using (64)Cu-DOTA-trastuzumab PET.

Autor: Mortimer JE; Department of Medical Oncology and Experimental Therapeutics, City of Hope, Duarte, California., Bading JR, Colcher DM, Conti PS, Frankel PH, Carroll MI, Tong S, Poku E, Miles JK, Shively JE, Raubitschek AA

Publikováno v: Journal of nuclear medicine : official publication, Society of Nuclear Medicine [J Nucl Med] 2014 Jan; Vol. 55 (1), pp. 23-9. Date of Electronic Publication: 2013 Dec 12.

Quantitative, simultaneous PET/MRI for intratumoral imaging with an MRI-compatible PET scanner.

Autor: Ng TS; Biological Imaging Center, Beckman Institute, California Institute of Technology, Pasadena, CA, USA., Bading JR, Park R, Sohi H, Procissi D, Colcher D, Conti PS, Cherry SR, Raubitschek AA, Jacobs RE

Publikováno v: Journal of nuclear medicine : official publication, Society of Nuclear Medicine [J Nucl Med] 2012 Jul; Vol. 53 (7), pp. 1102-9. Date of Electronic Publication: 2012 Jun 01.

Mathematical modeling of chimeric TCR triggering predicts the magnitude of target lysis and its impairment by TCR downmodulation.

Autor: James SE; Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA., Greenberg PD, Jensen MC, Lin Y, Wang J, Budde LE, Till BG, Raubitschek AA, Forman SJ, Press OW

Publikováno v: Journal of immunology (Baltimore, Md. : 1950) [J Immunol] 2010 Apr 15; Vol. 184 (8), pp. 4284-94. Date of Electronic Publication: 2010 Mar 10.

Minibodies and Multimodal Chromatography Methods: A Convergence of Challenge and Opportunity.

Autor: Gagnon P; Pete Gagnon is principal consultant at Validated Biosystems Inc., 240 Avenida Vista Montana, Suite 7F, San Clemente, CA USA 92672; 1-949-276-7477, fax 1-949-606-1904; www.validated.com . Chia-Wei Cheung, Mark A. Sherman, Andrew A. Raubitschek, and Paul J. Yazaki are with the department of cancer immunotherapeutics and tumor immunology at the City of Hope Medical Center's Beckman Research Institute in Duarte, CA; www.cityofhope.org/research/beckman-research-institute . Eric J. Lepin and Anna M. Wu are with the Crump Institute for Molecular Imaging's department of molecular and medical pharmacology at UCLA's David Geffen School of Medicine in Los Angeles, CA; www.crump.ucla.edu., Cheung CW, Lepin EJ, Wu AM, Sherman MA, Raubitschek AA, Yazaki PJ

Publikováno v: BioProcess international [Bioprocess Int] 2010 Feb; Vol. 8 (2), pp. 26-35.